GradedCalls Analysts
Loading the ledger…
Public news sources, graded against Yahoo Finance adjusted closes (adjusted for splits and dividends) through 16 Oct 2026. Not investment advice.
GradedCallsGradedCallsGradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Pfizer · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 30D
52.7/100Average of active call grades
GC score6/10GC 1→GC 10
GC 5–7. From 40 up to 70 is PROVISIONAL on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Geoff Meacham | Citi | 1 | 100% | 96.2/10010/10 |
| Vamil Divan | Guggenheim | 1 | 100% | 79.3/1008/10 |
| Rajesh Kumar | HSBC | 1 | 0% | 56.7 |
These calls count toward the overall factor once the horizon has a price. An open window is listed and is not in the average yet.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Carter GouldCantor | Target raise Desk rating stays Neutral | Hold | — | — | |||
| Oct 8, 2026 Supersedes Supersedes prior call on Sep 23, 2026 (within 90 days). Prior call |
6
In this factor
Superseded
3
Visible, not scored
Hit rate
33%
Active calls only
If followed
+6.3%
Active directional calls
Active calls on PFE were a full hit 33% of the time. Hit rate is not the rank.
| Jason Gerberry | BofA | 2 | 0% | 30/1004/10 |
| Michael Yee | UBS | 1 | 0% | 23.9/1003/10 |
| Chris SchottJPMorgan |
| Target raise Desk rating stays Neutral |
| Hold |
| — |
| — |
| Oct 8, 2026 Supersedes Supersedes prior call on Oct 1, 2026 (within 90 days). Prior call | Akash TewariJefferies | Target raise Desk rating stays Buy | Buy | — | — |
| Sep 10, 2026 Supersedes Supersedes prior call on Jul 6, 2026 (within 90 days). Prior call | Rajesh KumarHSBC | Target raise Desk rating stays Hold | Hold | $28.28 | +2.3% | Near |
| Aug 7, 2026 | Vamil DivanGuggenheim | Target cut Desk rating stays Buy | Buy | $28.45 | +6.3% | Hit |
| Jul 10, 2026 | Jason GerberryBofA | Target cut Desk rating stays Neutral | Hold | $26.76 | +12.7% | Miss |
| Apr 29, 2026 | Geoff MeachamCiti | Target raise Desk rating stays Neutral | Hold | $25.73 | +1.3% | Hit |
| Apr 13, 2026 | Michael YeeUBS | Target raise Desk rating stays Neutral | Hold | $25.51 | -3.5% | Miss |
| Apr 9, 2026 | Jason GerberryBofA | Target cut Desk rating stays Neutral | Hold | $25.24 | -4.1% | Miss |